Pharmaceutical Affairs Act Enforcement Rules Article 12

When a drug manufacturer engages in the wholesaling and exporting of its own products, the importing of raw materials for its own use, or the concurrent retailing of its own products in accordance with Article 16 of the Act, and does so at the same location at which it manufactures and processes drugs, those businesses may be concurrently managed by its manufacturing supervisor. When the pharmaceutical firm, however, concurrently engages in the sale of products other than its own products or establishes a separate place of business to engage in any of the foregoing businesses, it shall employ separate management personnel for those respective purposes, and shall register as a pharmaceutical firm that is a seller of drugs or medical devices.When a drug manufacturer, in accordance with Article 58 of the Act, contracts another manufacturer to manufacture drugs, the wholesaling, exporting, and retailing of those drugs may take place in accordance with the fore part of the preceding paragraph.
中文原文 藥事法施行細則第12條
藥品製造業者依本法第十六條規定在其製造加工之同一處所經營自製產品之批發、輸出、自用原料輸入及兼營自製產品之零售業務者,得由其監製人兼為管理之。
但兼營非本藥商產品之販賣業務或分設處所經營各該業務者,應分別聘管理人員,並辦理藥品販賣業之藥商登記。
藥品製造業者依本法第五十八條規定,委託他廠製造之產品,其批發、輸出及零售,得依前項前段規定辦理。

English translation for reference only; the Chinese text prevails. Not legal advice.